Opinion: It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough
The new drug lecanemab shows promise to one day treat Alzheimer's disease, but there's still a long way to go before it can be an effective and easily available treatment, writes Professor Jonathan Schott (UCL Queen Square Institute of Neurology) in The Guardian.
30 November 2022